Moderna, Inc. (MRNA)
55.12
+0.44
(+0.80%)
USD |
NASDAQ |
Apr 17, 12:35
Moderna Cash from Investing (Quarterly) : -48.00M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amgen, Inc. | -693.00M |
| Biogen, Inc. | -1.232B |
| Gilead Sciences, Inc. | -1.835B |
| Johnson & Johnson | -- |
| Arbutus Biopharma Corp. | -1.588M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 930.00M |
| Cash from Financing (Quarterly) | 581.00M |
| Free Cash Flow | -2.075B |
| Free Cash Flow Per Share (Quarterly) | 2.273 |
| Free Cash Flow to Equity (Quarterly) | 320.00M |
| Free Cash Flow to Firm (Quarterly) | 899.27M |
| Free Cash Flow Yield | -9.68% |